Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials
Org Biomol Chem 1(10):16841689 Sahin E, Bagci R, Bektur Aykanat NE, Kacar S, Sahinturk V (2020) Silymarin attenuated nonalcoholic fatty liver disease through the regulation of endoplasmic reticulum stress proteins GRP78 and XBP-1 in mice
Limited studies have designated the CAT phlegm score as the primary endpoint [24]
Some practices may refer complex cases to specialists, but straightforward prescribing often occurs in primary care
A preclinical in vivo study, perhaps in a mouse model, would let you see the blend's systemic effects on metabolic health over time
Check out my books on health and wellness